D-0003-2023 Class II Terminated

Recalled by Pfizer Inc. — New York, NY

Recall Details

Product Type
Drugs
Report Date
October 12, 2022
Initiation Date
September 27, 2022
Termination Date
August 21, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
103,150 10 mL vials

Product Description

Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) 25x10 mL Single-dose vial, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045 USA. NDC 0409-5921-16 (vial) 0409-5921-01 (carton)

Reason for Recall

Presence of Particulate Matter: A complaint was received for the presence of a hair in one vial.

Distribution Pattern

Distributed in the United States and Puerto Rico.

Code Information

Lot: 30-137-DK Exp. 1 DEC. 2022